Lifecore Biomedical, Inc.
LFCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001005286
No open-market purchases or sales by Lifecore Biomedical, Inc. insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Lifecore Biomedical, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 100 | 1 | 104 | +5 |
| Shares | 24.3M | 12.0K | 24.8M | +469.1K (+1.9%) |
| Value | $179.1M | $88.6K | $202.8M | +$23.8M (+13.3%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Lifecore Biomedical, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 82,794 | $677.0K | 0.06% |
| Dba Trading, LLC | 75,000 | $613.5K | 0.61% |
| D. E. Shaw & Co., Inc. | 37,428 | $306.2K | 0.00% |
| Two Sigma Investments, LP | 27,803 | $227.4K | 0.00% |
| Prelude Capital Management, LLC | 18,827 | $154.0K | 0.01% |
| Point72 Asset Management, L.P. | 15,656 | $128.1K | 0.00% |
| Two Sigma Advisers, LP | 15,264 | $124.9K | 0.00% |
| Jump Financial, LLC | 15,061 | $123.2K | 0.00% |
| Graham Capital Management, L.P. | 13,580 | $111.1K | 0.00% |
| Pinnacle Wealth Planning Services, Inc. | 7,355 | $60.2K | 0.01% |
| China Universal Asset Management Co., Ltd. | 6,105 | $49.9K | 0.00% |
| Torren Management, LLC | 2,312 | $18.9K | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,821 | $14.9K | 0.00% |
| Arbor Wealth Management LLC | 1,674 | $13.7K | 0.01% |
| Kemnay Advisory Services Inc. | 975 | $7.98K | 0.00% |
| GF Fund Management Co. Ltd. | 736 | $6.02K | 0.00% |
| Jones Financial Companies LLLP | 23 | $188 | 0.00% |
| Rothschild Investment LLC | 9 | $74 | 0.00% |
| SRS Capital Advisors, Inc. | 5 | $41 | 0.00% |
Sold out (14)
Institutions that held Lifecore Biomedical, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Landscape Capital Management, L.L.C. | 37,822 | $278.4K |
| Boothbay Fund Management, LLC | 29,964 | $220.5K |
| HRT Financial LP | 29,038 | $213.0K |
| Corsair Capital Management, L.P. | 20,000 | $147.2K |
| Tactive Advisors, LLC | 16,402 | $120.7K |
| ExodusPoint Capital Management, LP | 15,932 | $117.3K |
| Qube Research & Technologies Ltd | 14,133 | $104.0K |
| Balyasny Asset Management LLC | 13,699 | $100.8K |
| Manufacturers Life Insurance Company, The | 10,039 | $73.9K |
| Macquarie Group Ltd | 1,191 | $8.77K |
| Clear Street Markets LLC | 582 | $4.28K |
| Halbert Hargrove Global Advisors, LLC | 230 | $1.69K |
| SWAN Capital LLC | 80 | $589 |
| Advisor Group Holdings, Inc. | 53 | $390 |
Not filed for Q4 2025 yet (1)
Institutions that held Lifecore Biomedical, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Corton Capital Inc. | 12,043 | $88.6K |